Understanding Symptom Recognition and Treatment Decision-making in Hispanic/Latino Lung Cancer Patients
The purpose of the study is to understand why Hispanic/Latino patients with lung cancer are diagnosed later than other groups.
Checked against the public recordLast updated Feb 11, 2016 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Not specified
- Study type
- Observational
- Phase
- Not applicable
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Interventions being studied
- Behavioral: semi-structured interviews
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * Self-identified Hispanic/Latino patients with biopsy-proven primary lung cancer treated at MSKCC, including stages of disease I-IV * 18 years of age or older * Fluent in English or Spanish * Patients must reside in the U.S Exclusion Criteria: * Spanish-surnamed patients who do not self identify as Hispanic/Latino (e.g., Philippines-born individuals)
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Memorial Sloan Kettering Cancer CenterNew York, New York
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Feb 11, 2016. Always confirm current availability with the study team.